InternationalUSRemember you can easily switch between MIP US and MIP International at any time

IP Clinic: My company is interested in open innovation, but how can we protect our rights?


More and more companies are considering using open innovation models to develop new and innovative products. But how should we structure agreements with third parties that protect our rights?

The in-house counsel

Open innovation started in the consumer electronics domain, gradually moved to consumer goods and is now used in more complex healthcare technologies and pharma.

At Philips we believe open innovation is here to stay and are entering...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Matal also had a tip for those unsure how to pronounce USPTO Director nominee Andrei Iancu's surname: "Say it as if… https://t.co/DfwG58b5OU

Oct 19 2017 03:45 ·  reply ·  retweet ·  favourite
ManagingIP profile

Matal pointed out "two sleeper cases" he thinks have a shot at making it to SCOTUS - Unwired Planet and Secure Axce… https://t.co/AUw9cmQziV

Oct 19 2017 03:43 ·  reply ·  retweet ·  favourite
ManagingIP profile

One for fans of TV format disputes (addresses copyright, breach of confidence & passing off) https://t.co/Qe1lr1NrSq

Oct 19 2017 02:03 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

October 2017

Courts grapple with scope of patent protection

The Supreme Court’s decision in Actavis v Eli Lilly introduced a doctrine of equivalents and arguably also established a doctrine of prosecution history estoppel in the UK. We look at the law across Europe, and the impact the decision might have. Kingsley Egbuonu, Michael Loney and James Nurton set the scene



Most read articles

Supplements